BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 16677275)

  • 1. Transient effect of epoprostenol and sildenafil combined with iNO for pulmonary hypertension in congenital diaphragmatic hernia.
    De Luca D; Zecca E; Vento G; De Carolis MP; Romagnoli C
    Paediatr Anaesth; 2006 May; 16(5):597-8. PubMed ID: 16677275
    [No Abstract]   [Full Text] [Related]  

  • 2. Sildenafil use in congenital diaphragmatic hernia.
    Hunter L; Richens T; Davis C; Walker G; Simpson JH
    Arch Dis Child Fetal Neonatal Ed; 2009 Nov; 94(6):F467. PubMed ID: 19846401
    [No Abstract]   [Full Text] [Related]  

  • 3. Cardiovascular effects of sildenafil in neonates and infants with congenital diaphragmatic hernia and pulmonary hypertension.
    Noori S; Friedlich P; Wong P; Garingo A; Seri I
    Neonatology; 2007; 91(2):92-100. PubMed ID: 17344658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute and chronic effects of sildenafil in patients with pulmonary arterial hypertension.
    Preston IR; Klinger JR; Houtches J; Nelson D; Farber HW; Hill NS
    Respir Med; 2005 Dec; 99(12):1501-10. PubMed ID: 15890512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of sildenafil to facilitate weaning from inhaled nitric oxide in children with pulmonary hypertension following surgery for congenital heart disease.
    Lee JE; Hillier SC; Knoderer CA
    J Intensive Care Med; 2008; 23(5):329-34. PubMed ID: 18701525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The immediate response to the administration of inhaled nitric oxide in a newborn infant with congenital diaphragmatic hernia and pulmonary hypertension].
    Figueras Aloy J; Sorni Hubrecht A; Botet Moussons F; Rodríguez Miguélez JM; Jiménez González R
    An Esp Pediatr; 1996 Jan; 44(1):70-2. PubMed ID: 8849068
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of rebound pulmonary hypertension: why not sildenafil?
    Raja SG
    Anesthesiology; 2004 Dec; 101(6):1480; author reply 1481. PubMed ID: 15564966
    [No Abstract]   [Full Text] [Related]  

  • 8. Combination pharmacotherapy for severe neonatal pulmonary hypertension.
    Filan PM; McDougall PN; Shekerdemian LS
    J Paediatr Child Health; 2006 Apr; 42(4):219-20. PubMed ID: 16630327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary hypertension: inhaled nitric oxide, sildenafil and natriuretic peptides.
    Steiner MK; Preston IR; Klinger JR; Hill NS
    Curr Opin Pharmacol; 2005 Jun; 5(3):245-50. PubMed ID: 15907910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute pulmonary hypertension in infants and children: cGMP-related drugs.
    Fraisse A; Wessel DL
    Pediatr Crit Care Med; 2010 Mar; 11(2 Suppl):S37-40. PubMed ID: 20216161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of rebound and chronic pulmonary hypertension with oral sildenafil in an infant with congenital diaphragmatic hernia.
    Keller RL; Hamrick SE; Kitterman JA; Fineman JR; Hawgood S
    Pediatr Crit Care Med; 2004 Mar; 5(2):184-7. PubMed ID: 14987351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iloprost as 'rescue' therapy for pulmonary hypertension of the neonate.
    De Luca D; Zecca E; Piastra M; Romagnoli C
    Paediatr Anaesth; 2007 Apr; 17(4):394-5. PubMed ID: 17359413
    [No Abstract]   [Full Text] [Related]  

  • 13. Sildenafil prevents rebound pulmonary hypertension after withdrawal of nitric oxide in children.
    Namachivayam P; Theilen U; Butt WW; Cooper SM; Penny DJ; Shekerdemian LS
    Am J Respir Crit Care Med; 2006 Nov; 174(9):1042-7. PubMed ID: 16917115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of pulmonary arterial hypertension.
    Humbert M; Sitbon O; Simonneau G
    N Engl J Med; 2004 Sep; 351(14):1425-36. PubMed ID: 15459304
    [No Abstract]   [Full Text] [Related]  

  • 15. Sildenafil treatment of primary pulmonary hypertension.
    Laupland KB; Helmersen D; Zygun DA; Viner SM
    Can Respir J; 2003; 10(1):48-50. PubMed ID: 12624621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sildenafil, nitric oxide, and acute lung injury: pathophysiology beats pharmacotherapy?
    Schulze-Neick I; Redington AN
    Pediatr Res; 2004 Mar; 55(3):370-1. PubMed ID: 14711895
    [No Abstract]   [Full Text] [Related]  

  • 17. Sildenafil in neonatal pulmonary hypertension due to impaired alveolarisation and plexiform pulmonary arteriopathy.
    Chaudhari M; Vogel M; Wright C; Smith J; Haworth SG
    Arch Dis Child Fetal Neonatal Ed; 2005 Nov; 90(6):F527-8. PubMed ID: 16244212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of sildenafil on pulmonary artery pressure, systemic pressure, and nitric oxide utilization in patients with left ventricular assist devices.
    Klodell CT; Morey TE; Lobato EB; Aranda JM; Staples ED; Schofield RS; Hess PJ; Martin TD; Beaver TM
    Ann Thorac Surg; 2007 Jan; 83(1):68-71; discussion 71. PubMed ID: 17184632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long survival of congenital alveolar capillary dysplasia patient with NO inhalation and epoprostenol: effect of sildenafil, beraprost and bosentan.
    Kodama Y; Tao K; Ishida F; Kawakami T; Tsuchiya K; Ishida K; Takemura T; Nakazawa A; Matsuoka K; Yoda H
    Pediatr Int; 2012 Dec; 54(6):923-6. PubMed ID: 23279022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sildenafil can increase the response to inhaled nitric oxide.
    Bigatello LM; Hess D; Dennehy KC; Medoff BD; Hurford WE
    Anesthesiology; 2000 Jun; 92(6):1827-9. PubMed ID: 10839936
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.